XML 75 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 8 Months Ended 12 Months Ended
May 31, 2021
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Performance-Vesting RSUs [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of equity instruments awarded in period     431,241  
Vesting     419,736  
Weighted-average grant date fair value per share, vested     $ 8.75  
Weighted-average grant-date fair value of performance-vesting restricted stock     4.62 $ 7.42
Weighted-Average Grant Date Fair Value Per Share, granted     13.99  
Performance-vesting Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted-average grant date fair values of awards granted   $ 8.75 $ 13.99 $ 5.71
Share based compensation arrangement by Share based payment award options vested in period fair value 1     $ 6.5 $ 3.2
Time-vesting RSU and Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of equity instruments awarded in period     692,236  
Vesting     854,293  
Weighted-average grant date fair value per share, vested     $ 8.31  
Weighted-average grant-date fair value of performance-vesting restricted stock     6.81 $ 8.20
Weighted-Average Grant Date Fair Value Per Share, granted     11.34  
Weighted-average grant date fair values of awards granted   $ 8.75 $ 11.34 $ 6.68
Share based compensation arrangement by Share based payment award options vested in period fair value 1   $ 0.6 $ 11.3 $ 3.9
Equity Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation cost recognized for awards under the Equity Plan   10.8 14.2 20.2
Tax benefits recognized   $ 2.0 2.5 2.9
Unrecognized compensation cost related to nonvested awards under the Equity Plan     $ 10.7  
Expected weighted average period to recognized compensation cost related to nonvested awards under the Equity Plan     1 year  
Equity Plan [Member] | Performance-vesting Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of awards vested       $ 5.4
Vesting     30,370 747,407
Weighted-average grant date fair value per share, vested       $ 6.89
Share based compensation arrangement by Share based payment award options vested in period fair value 1     $ 0.4 $ 6.2
2021 Long-Term Stock Incentive Plan [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares of common stock available for issuance     11,111,111  
2021 Long-Term Stock Incentive Plan [Member] | Time-vesting RSUs [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of equity instruments awarded in period   1,916,043 593,205 535,516
Vesting period     3 years  
2021 Long-Term Stock Incentive Plan [Member] | Time-vesting RSUs [Member] | Non-Employee [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of equity instruments awarded in period     318,292  
2021 Long-Term Stock Incentive Plan [Member] | Time-vesting Restricted Stock [Member] | Chief Executive Officer [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of equity instruments awarded in period   222,222    
2021 Long-Term Stock Incentive Plan [Member] | Performance-Vesting RSUs [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of equity instruments awarded in period   1,733,404 431,241 709,148
Vesting period   3 years 3 years 3 years
2021 Long-Term Stock Incentive Plan [Member] | Performance-vesting Restricted Stock [Member] | Chief Executive Officer [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of equity instruments awarded in period 777,777